Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001209191-23-052050

Chief Strategy Officer bought 42,300 shares at $5.91 ($249,993)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Turner Bruce Chief Strategy Officer 2023-10-02 Purchase +42,300 $5.91 $249,993 42,300 D: show line 1 in the form
Open-market purchases · 42,300 sh · avg $5.91 · $249,993
Loading xslF345X05/doc4.xml…